United Imaging Intelligence's Innovations in Radiology AI at ECR 2026

At the European Congress of Radiology (ECR) 2026, themed "Rays of Knowledge," United Imaging Intelligence (UII) unveiled a suite of pioneering AI solutions that highlight the transformative potential of validated clinical expertise in radiology. UII's presentation emphasized not only the scientific rigor behind their innovations but also their practical application in everyday healthcare settings.

Comprehensive Portfolio of AI Solutions

With 30 CE-certified medical AI applications, UII has established one of the most comprehensive AI portfolios available in the European market. This portfolio demonstrates a high level of technological maturity, facilitating real-world clinical integration across various imaging modalities and therapeutic areas, including neuroradiology, cardiovascular diseases, oncology, and more. Specialists from Europe, Asia, North America, and South America praised UII's offerings, noting their extensive coverage and uniqueness as a holistic AI solution that significantly assists clinicians in their daily practices.

During the conference, UII introduced the clinical portal uAI (uCP), a unified platform housing over 60 AI applications designed for diverse imaging modalities. This development not only illustrates UII's commitment to advancing clinical practice but also towards scalable and internationally compliant healthcare solutions.

Advancing Radiology Knowledge with Foundation Models

Building on validated radiological knowledge, UII showcased its suite of medical foundation models under the name uAI NEXUS. These models integrate image, language, speech, and video capabilities, transforming domain expertise into a scalable AI capacity. The large-scale medical image model, trained on millions of imaging datasets and refined through real-world deployment, enables advanced reasoning directly within clinical workflows.

The debut of the uAI Insight Image-to-Report AI agent marked a significant milestone for AI applications in Europe. This agent, along with specialized AI tools for thoracic scans and brain MRIs, can accurately detect a plethora of conditions—including 73 thoracic and 47 neurological findings—from single scans, while also generating structured preliminary reports to streamline interpretation processes.

Another notable innovation, the uAI ultrasound agent, employs multimodal foundation models and digital twin technology, showcasing consistent and high-quality scanning alongside real-time AI-driven reporting. Live demonstrations at ECR 2026 underscored the embodied AI’s capability to operate directly in clinical settings.

Expanding the AI Ecosystem in Healthcare

Beyond these flagship innovations, UII presented a broader ecosystem of AI agents that encompass diagnostic imaging, surgical planning, hospital activities, and clinical research. Collectively, these solutions signify a transition from single-task algorithms to collaborative, workflow-oriented intelligence across healthcare systems.

The practical application of clinically validated AI underscores its importance in enhancing patient care. Currently, clinicians in several European countries, including Poland, the UK, Italy, Romania, and Bosnia-Herzegovina, are already utilizing UII's AI solutions. Ongoing collaborations aim to broaden access to AI-driven diagnostics for patient populations across the region.

For instance, at Policlinico Casilino, UII's CE-certified AI FFR-CT technology enables rapid and non-invasive assessments of coronary blood flow. Dr. Armando Fusco explains that this technology facilitates confident therapeutic decision-making, reduces hospital stays for emergency patients, and helps avoid unnecessary invasive procedures in complex cases, particularly for patients with moderate stenosis.

At STERMED, CE-certified AI applications for MRI in prostate and liver imaging serve as trusted clinical assistants for Dr. Marcin Sternicki. They enhance diagnostic confidence by providing precise quantitative measurements that are challenging and time-consuming to obtain manually. The prostate MRI AI can also automatically produce structured PI-RADS maps, providing clear visual documentation to assist in clinical decision-making.

During ECR 2026, UII reaffirmed its principles for AI development, rooted in clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiological knowledge into a dynamic dataset that continually evolves to elevate clinical standards and advance intelligent healthcare in Europe and beyond.

Disclaimer: The mentioned products and features may not be available in all countries, and their future availability cannot be guaranteed. Not all AI applications are CE marked or FDA-approved.